Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Harmony Biosciences Holdings
Harmony Biosciences Holdings
(HRMY)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Wakix
Pitolisant
2019-08-14
2026-2030
Obstructive sleep apnea
,
Narcolepsy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pitolisant
healthy volunteers/patients
,
diabetes mellitus
,
type 1 diabetes mellitus
,
hypoglycemia
,
alcoholic intoxication
,
alcohol drinking
,
substance-related disorders
,
renal insufficiency
,
alcoholism
,
nervous system alcohol-induced disorders
,
schizophrenia
,
myotonic dystrophy
,
autism spectrum disorder
,
disorders of excessive somnolence
,
sleepiness
,
narcolepsy
,
cataplexy
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
prader-willi syndrome
,
parkinson disease
,
idiopathic hypersomnia
,
sleep wake disorders
,
parasomnias
,
syndrome
,
restless legs syndrome
,
psychomotor agitation
,
pregnancy rate
,
anhedonia
,
cognition
Losartan
pancreatic neoplasms
,
hypertension
,
inflammation
,
graft rejection
Aspartame
leukemia
,
myeloid leukemia
,
ulcerative colitis
,
colitis
,
ulcer
,
rheumatoid arthritis
,
myeloid leukemia acute
,
atopic dermatitis
,
hidradenitis suppurativa
,
eczema
,
dermatitis
,
crohn disease
,
pathologic constriction
,
inflammatory bowel diseases
,
intestinal diseases
Clemizole
myoclonic epilepsies
,
seizures
,
lennox gastaut syndrome
,
syndrome
Phenylacetic acid
pain
,
sprains and strains
,
low back pain
,
rheumatoid arthritis
,
arthritis
,
osteoarthritis
Zyn002
drug interactions
,
digeorge syndrome
,
22q11 deletion syndrome
,
syndrome
,
fragile x syndrome
Gluconorm
healthy volunteers/patients
,
drug interactions
,
obesity
,
neoplasms
,
mitochondrial diseases
,
stroke
,
hypersensitivity
,
parkinson disease
,
recurrence
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
gastrointestinal stromal tumors
,
lymphoma
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
malaria
,
rheumatoid arthritis
,
arthritis
,
sickle cell anemia
,
hyperuricemia
,
renal insufficiency
,
overweight
,
hypoglycemia
,
fibrosis
,
cystic fibrosis
,
hypertension
,
cardiovascular diseases
,
chronic renal insufficiency
,
kidney diseases
,
hypercholesterolemia
,
coronary disease
,
atherosclerosis
,
type 2 diabetes mellitus
,
diabetes mellitus
,
diabetes complications
,
morbid obesity
,
bariatric surgery
,
pancreatitis
,
pancreatic neoplasms
,
heart failure
,
prediabetic state
,
glucose intolerance
,
exocrine pancreatic insufficiency
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use